The Role of Conventional MR Imaging Sequences in the Evaluation of Neurocysticercosis: Impact on Characterization of the Scolex and Lesion Burden

References

1. ↵
   Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;39:1025–40

   CrossRefPubMedWeb of Science
2. ↵
   Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005;4:653–61

   CrossRefPubMedWeb of Science
3. ↵
   Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559–64

   Abstract/FREE Full Text
4. ↵
   Zee CS, Go JL, Kim PE, et al. Imaging of neurocysticercosis. Neuroimaging Clin N Am 2000;10:391–407

   PubMedWeb of Science
5. ↵
   Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop 2003;87:71–78

   CrossRefPubMedWeb of Science
6. ↵
   Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 2003;16:411–19

   CrossRefPubMedWeb of Science
7. ↵
   Garcia HH, Gonzalez AE, Evans CA, et al. Taenia solium cysticercosis. Lancet 2003;362:547–56

   CrossRefPubMedWeb of Science
8. ↵
   Castillo M. Imaging of neurocysticercosis. Semin Roentgenol 2004;39:465–73

   CrossRefPubMed
9. ↵
   Dumas JL, Visy JM, Belin C, et al. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology 1997;39:12–18

   CrossRefPubMedWeb of Science
10. ↵
    Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR Am J Neuroradiol 1986;7:235–42

    Abstract/FREE Full Text
11. ↵
    Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177–83

    Abstract/FREE Full Text
12. ↵
    Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15:747–56

    Abstract/FREE Full Text
13. ↵
    Poeschl P, Janzen A, Schuierer G, et al. Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy. AJNR Am J Neuroradiol 2006;27:653–55

    Abstract/FREE Full Text
14. ↵
    Yancey LS, Diaz-Marchan PJ, White AC. Cysticercosis: recent advances in diagnosis and management of neurocysticercosis. Curr Infect Dis Rep 2005;7:39–47

    CrossRefPubMed
15. ↵
    Flisser A, Sarti E, Lightowlers M, et al. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 2003;87:43–51

    CrossRefPubMedWeb of Science
16. ↵
    Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 1999;29:1203–09

    Abstract/FREE Full Text
17. ↵
    Prabhakaran V, Rajshekhar V, Murrell KD, et al. Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg 2004;98:478–84

    Abstract/FREE Full Text
18. ↵
    Ishikawa E, Komatsu Y, Kikuchi K, et al. Neurocysticercosis as solitary parenchymal lesion confirmed by mitochondrial deoxyribonucleic acid sequence analysis. Neurol Med Chir (Tokyo)2007;47:40–44

    CrossRefPubMed
19. ↵
    do Amaral LL, Ferreira RM, da Rocha AJ, et al. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 2005;16:127–44

    CrossRefPubMed
20. ↵
    Sander HW, Castro C. Images in clinical medicine: neurocysticercosis. N Engl J Med 2004;350:266

    CrossRefPubMed
21. ↵
    Silbert PL, Gubbay SS, Khangure M. Distinctive MRI findings in a case of neurocysticercosis. Med J Aust 1993;159:185–86

    PubMed
22. ↵
    Sheth TN, Pillon L, Keystone J, et al. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol 1998;19:79–82

    Abstract
23. ↵
    Amaral L, Maschietto M, Maschietto R, et al. Unusual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuropsiquiatr 2003;61:533–41. Epub 2003 Sep 16

    PubMed
24. ↵
    Chang KH, Lee JH, Han MH, et al. The role of contrast-enhanced MR imaging in the diagnosis of neurocysticercosis. AJNR Am J Neuroradiol 1991;12:509–12

    Abstract/FREE Full Text
25. ↵
    Schorner W, Laniado M, Niendorf HP, et al. Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA. AJNR Am J Neuroradiol 1986;7:1013–20

    Abstract/FREE Full Text
26. Yuh WT, Tali ET, Nguyen HD, et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995;16:373–80

    Abstract/FREE Full Text
27. ↵
    Runge VM, Wells JW, Williams NM, et al. The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection. Invest Radiol 1996;31:294–99

    CrossRefPubMed
28. ↵
    Singh S, Gibikote SV, Shyamkumar NK. Isolated fourth ventricular cysticercus cyst: MR imaging in 4 cases with short literature review. Neurol India 2003;51:394–96

    PubMed
29. ↵
    Tsuchiya K, Inaoka S, Mizutani Y, et al. Fast fluid-attenuated inversion-recovery MR of intracranial infections. AJNR Am J Neuroradiol 1997;18:909–13

    Abstract/FREE Full Text